Purple Urine Bag Syndrome in a Critically Ill Patient: Case Report

2020 ◽  
Vol 2 (11) ◽  
pp. 2445-2447
Author(s):  
Heidi Angela Fernandez ◽  
Martín Lescano Ruiz ◽  
Stephanie González Jara
2019 ◽  
Vol 45 (3) ◽  
pp. 570-572
Author(s):  
Stefania Capra ◽  
Sujita W. Narayan ◽  
Kaitlyn Parratt ◽  
Asad E. Patanwala

2020 ◽  
Vol 49 (1) ◽  
pp. 331-331
Author(s):  
Jamis Gouge ◽  
Aftab Ahmed ◽  
Thomas Rogers ◽  
David Mathis

2007 ◽  
Vol 25 (7) ◽  
pp. 861.e5-861.e6 ◽  
Author(s):  
Yu-Jang Su ◽  
Wen-Han Chang ◽  
Yen-Chun Lai

2012 ◽  
Vol 13 (3) ◽  
pp. 358 ◽  
Author(s):  
O-nyoung Kwon ◽  
Seung Hyun Cho ◽  
Chang Keun Park ◽  
Sung Hee Mun

CHEST Journal ◽  
2010 ◽  
Vol 138 (4) ◽  
pp. 72A
Author(s):  
Bassel Ericsoussi ◽  
Michael A. Markos ◽  
Ruxana T. Sadikot ◽  
Mehmet S. Ozcan

Author(s):  
Carlos Rubiano ◽  
Kathleen Tompkins ◽  
Subhashini A Sellers ◽  
Brian Bramson ◽  
Joseph Eron ◽  
...  

Abstract We present a case of a critically ill patient with COVID-19 found to have AIDS and Pneumocystis jirovecii pneumonia (PCP). COVID-19 and PCP co-occurrence is increasingly reported and may complicate diagnostic and therapeutic strategies. Patients with severe COVID-19 should be screened for underlying immunocompromise and coinfections should be considered.


2021 ◽  
pp. 194187442110043
Author(s):  
Henly Hewan ◽  
Annie Yang ◽  
Aparna Vaddiparti ◽  
Benison Keung

In late 2019, the novel coronavirus, SARS-CoV-2, and the disease it causes, COVID-19, was identified. Since then many different neurological manifestations of COVID-19 have been well reported. Movement abnormalities have been rarely described. We report here a critically ill patient with COVID-19 who developed generalized myoclonus during the recovery phase of the infection. Myoclonus was associated with cyclical fevers and decreased alertness. Movements were refractory to conventional anti-epileptic therapies. There was concern that myoclonus could be part of a post-infectious immune-mediated syndrome. The patient improved fully with a 4-day course of high-dose steroids. Our experience highlights a rare, generalized myoclonus syndrome associated with COVID-19 that may be immune-mediated and is responsive to treatment.


2007 ◽  
Vol 13 (2) ◽  
pp. 153-158 ◽  
Author(s):  
David Kem ◽  
Jordan Metcalf ◽  
Ana Cornea ◽  
Monica Dunnam ◽  
Alice Engelbrecht ◽  
...  

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Qingpin Fu ◽  
Difei Li ◽  
Wei He ◽  
Qiuxuan Zeng ◽  
Jieya Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document